188 related articles for article (PubMed ID: 33302861)
1. New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications.
Clerc OF; Haaf P; Buechel RR; Gaemperli O; Zellweger MJ
Curr Radiopharm; 2021; 14(3):273-299. PubMed ID: 33302861
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
Huang S; Frangogiannis NG
Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
[TBL] [Abstract][Full Text] [Related]
3. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
4. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.
Andreadou I; Cabrera-Fuentes HA; Devaux Y; Frangogiannis NG; Frantz S; Guzik T; Liehn EA; Gomes CPC; Schulz R; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1117-1130. PubMed ID: 30825305
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor receptor-associated factors: interacting protein with forkhead-associated domain inhibition decreases inflammatory cell infiltration and cardiac remodelling after acute myocardial infarction.
Jiang Y; Li X; Xu H; Gu Y; Shi F; Wang F; Zhang X
Interact Cardiovasc Thorac Surg; 2020 Jul; 31(1):85-92. PubMed ID: 32380527
[TBL] [Abstract][Full Text] [Related]
6. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
Ong SB; Hernández-Reséndiz S; Crespo-Avilan GE; Mukhametshina RT; Kwek XY; Cabrera-Fuentes HA; Hausenloy DJ
Pharmacol Ther; 2018 Jun; 186():73-87. PubMed ID: 29330085
[TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome in acute myocardial infarction.
Toldo S; Abbate A
Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
9. Targeting inflammatory pathways in myocardial infarction.
Christia P; Frangogiannis NG
Eur J Clin Invest; 2013 Sep; 43(9):986-95. PubMed ID: 23772948
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications.
Krenning BJ; der Heiden KV; Duncker DJ; de Jong M; Bernsen MR
Curr Radiopharm; 2021; 14(3):184-208. PubMed ID: 33045975
[TBL] [Abstract][Full Text] [Related]
11. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction.
Kologrivova I; Shtatolkina M; Suslova T; Ryabov V
Front Immunol; 2021; 12():664457. PubMed ID: 33868315
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and left ventricular remodelling after myocardial infarction.
Hori M; Nishida K
Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
[TBL] [Abstract][Full Text] [Related]
13. Colchicine and myocardial infarction: A review.
Akodad M; Sicard P; Fauconnier J; Roubille F
Arch Cardiovasc Dis; 2020 Oct; 113(10):652-659. PubMed ID: 32712201
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction.
Seropian IM; Toldo S; Van Tassell BW; Abbate A
J Am Coll Cardiol; 2014 Apr; 63(16):1593-603. PubMed ID: 24530674
[TBL] [Abstract][Full Text] [Related]
15. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
[TBL] [Abstract][Full Text] [Related]
16. S100A9 Links Inflammation and Repair in Myocardial Infarction.
Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
[TBL] [Abstract][Full Text] [Related]
17. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC
Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265
[TBL] [Abstract][Full Text] [Related]
18. CD8
Ilatovskaya DV; Pitts C; Clayton J; Domondon M; Troncoso M; Pippin S; DeLeon-Pennell KY
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H581-H596. PubMed ID: 31322426
[TBL] [Abstract][Full Text] [Related]
19. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
